Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Revenue

In the year 2023, Iovance Biotherapeutics had annual revenue of $1.19M. Revenue in the quarter ending December 31, 2023 was $482.00K.

• Revenue (ttm): $1.19M
• Revenue Growth: n/a
• P/S Ratio: 3,201.81
• Revenue / Employee: $2,135
• Employees: 557
• Market Cap: 3.81B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	0	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.